Mayuko Inagaki

972 total citations · 1 hit paper
9 papers, 759 citations indexed

About

Mayuko Inagaki is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Mayuko Inagaki has authored 9 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Hematology. Recurrent topics in Mayuko Inagaki's work include Atrial Fibrillation Management and Outcomes (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Mast cells and histamine (2 papers). Mayuko Inagaki is often cited by papers focused on Atrial Fibrillation Management and Outcomes (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Mast cells and histamine (2 papers). Mayuko Inagaki collaborates with scholars based in United States and Japan. Mayuko Inagaki's co-authors include Stanley J. Hollenbach, Francis DeGuzman, Uma Sinha, David R. Phillips, Athiwat Hutchaleelaha, Genmin Lu, Pamela B. Conley, Peng Luan, Keith Abe and Mark J. Karbarz and has published in prestigious journals such as Circulation, Nature Medicine and Blood.

In The Last Decade

Mayuko Inagaki

9 papers receiving 736 citations

Hit Papers

A specific antidote for reversal of anticoagulation by di... 2013 2026 2017 2021 2013 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
    2013 533 citations Genmin Lu, Francis DeGuzman et al. Nature Medicine profile →

Peers

Mayuko Inagaki
Sebastián F. Ameriso United States
Kousuke Kumeda Japan
Zihui Xiao China
Marie‐Laure Ozoux France
Mustafa Altınbaş Türkiye
Melanie McCabe White United States
Yoshitaka Hosaka Japan
Porama Thanaporn United States
Jessica Hirsch United States
H. Kessels Netherlands
Sebastián F. Ameriso United States
Mayuko Inagaki
Citations per year, relative to Mayuko Inagaki Mayuko Inagaki (= 1×) peers Sebastián F. Ameriso

Countries citing papers authored by Mayuko Inagaki

Since Specialization
Citations

This map shows the geographic impact of Mayuko Inagaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayuko Inagaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayuko Inagaki more than expected).

Fields of papers citing papers by Mayuko Inagaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayuko Inagaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayuko Inagaki. The network helps show where Mayuko Inagaki may publish in the future.

Co-authorship network of co-authors of Mayuko Inagaki

This figure shows the co-authorship network connecting the top 25 collaborators of Mayuko Inagaki. A scholar is included among the top collaborators of Mayuko Inagaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayuko Inagaki. Mayuko Inagaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Inagaki, Mayuko, et al.. (2023). High-throughput analysis system of interaction kinetics for data-driven antibody design. Scientific Reports. 13(1). 19417–19417. 10 indexed citations
2.
Coffey, Greg, Francis DeGuzman, Yvonne Pak, et al.. (2014). The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer. Journal of Pharmacology and Experimental Therapeutics. 351(3). 538–548. 73 indexed citations
3.
Lu, Genmin, Francis DeGuzman, Stanley J. Hollenbach, et al.. (2013). A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nature Medicine. 19(4). 446–451. 533 indexed citations breakdown →
4.
Hollenbach, Stanley J., Francis DeGuzman, J Malinowski, et al.. (2013). PRT064445 reverses rivaroxaban induced anticoagulation in a rabbit liver laceration "treatment" model. European Heart Journal. 34(suppl 1). P241–P241. 9 indexed citations
5.
6.
André, Patrick, Francis DeGuzman, Helena Haberstock-Debic, et al.. (2011). Thienopyridines, but Not Elinogrel, Result in Off-Target Effects at the Vessel Wall That Contribute to Bleeding. Journal of Pharmacology and Experimental Therapeutics. 338(1). 22–30. 21 indexed citations
7.
Coffey, Greg, Francis DeGuzman, Mayuko Inagaki, et al.. (2011). Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis. Journal of Pharmacology and Experimental Therapeutics. 340(2). 350–359. 91 indexed citations
8.
Coffey, Greg, Mayuko Inagaki, Yvonne Pak, et al.. (2010). Specific Inhibition of Syk Suppresses Leukocyte Immune Function and Alleviates Inflammation In Rodent Models of Rheumatoid Arthritis. Blood. 116(21). 1727–1727. 2 indexed citations
9.
André, Patrick, Pamela B. Conley, Francis DeGuzman, et al.. (2008). Abstract 1718: Combination of Direct Acting FXa Inhibitor and P2Y 12 Antagonist at Non-Effective doses Provides Significant Inhibition of Arterial Thrombosis. Circulation. 118(suppl_18). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastián F. Ameriso Breakdown of academic impact, for papers by Kousuke Kumeda Breakdown of academic impact, for papers by Zihui Xiao Breakdown of academic impact, for papers by Marie‐Laure Ozoux Breakdown of academic impact, for papers by Mustafa Altınbaş Breakdown of academic impact, for papers by Melanie McCabe White Breakdown of academic impact, for papers by Yoshitaka Hosaka Breakdown of academic impact, for papers by Porama Thanaporn Breakdown of academic impact, for papers by Jessica Hirsch Breakdown of academic impact, for papers by H. Kessels
Rankless by CCL
2026